Stocks ContributorsNurix Therapeutics, Inc. (NRIX) reports Q2 loss, lags revenue estimates
Zacks Investment Research
Zacks Investment Research provides unbiased investment research and tools to help individuals and institutional investors make confident investing decisions.
Latest Posts by Zacks Investment Research
Stocks ContributorsPepsiCo (PEP) Q2 earnings and revenues surpass estimates
Stocks ContributorsA positive outlook as Q2 earnings season gets underway
Stocks ContributorsPenguin Solutions, Inc. (PENG) surpasses Q3 earnings and revenue estimates
Stocks ContributorsWill HubSpot (HUBS) beat estimates again in its next earnings report?
Stocks ContributorsLevi Strauss' Q2 earnings upcoming: What's ahead for the stock?
Stocks ContributorsQ2 earnings season nears kickoff: Bank earnings in focus
Stocks ContributorsBassett Furniture (BSET) Q2 earnings and revenues beat estimates
Stocks ContributorsProgress Software (PRGS) Q2 earnings and revenues surpass estimates
Stocks ContributorsWhat will Q2 earnings season show?